0.5716
price up icon0.72%   0.0041
after-market After Hours: .58 0.0084 +1.47%
loading
Amarin Corp Adr stock is traded at $0.5716, with a volume of 1.06M. It is up +0.72% in the last 24 hours and up +8.81% over the past month. Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
See More
Previous Close:
$0.5675
Open:
$0.57
24h Volume:
1.06M
Relative Volume:
0.71
Market Cap:
$235.12M
Revenue:
$306.91M
Net Income/Loss:
$-59.11M
P/E Ratio:
-3.8107
EPS:
-0.15
Net Cash Flow:
$6.35M
1W Performance:
-1.72%
1M Performance:
+8.81%
6M Performance:
-18.96%
1Y Performance:
-53.53%
1-Day Range:
Value
$0.5601
$0.5843
1-Week Range:
Value
$0.54
$0.6138
52-Week Range:
Value
$0.4303
$1.36

Amarin Corp Adr Stock (AMRN) Company Profile

Name
Name
Amarin Corp Adr
Name
Phone
353 1 6699 020
Name
Address
SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2
Name
Employee
275
Name
Twitter
@amarincorp
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
AMRN's Discussions on Twitter

Compare AMRN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
AMRN
Amarin Corp Adr
0.5716 235.12M 306.91M -59.11M 6.35M -0.15
Drug Manufacturers - General icon
LLY
Lilly Eli Co
870.37 827.20B 40.86B 8.37B -2.28B 9.25
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
87.17 386.95B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
JNJ
Johnson Johnson
153.51 344.63B 88.82B 14.07B 19.03B 5.79
Drug Manufacturers - General icon
ABBV
Abbvie Inc
192.97 341.01B 56.33B 4.28B 15.62B 2.40
Drug Manufacturers - General icon
MRK
Merck Co Inc
88.05 251.88B 64.17B 17.12B 14.84B 6.7297

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-20-23 Resumed JP Morgan Underweight
Oct-25-23 Downgrade Jefferies Buy → Hold
Jan-06-23 Upgrade Jefferies Hold → Buy
May-06-22 Downgrade JP Morgan Neutral → Underweight
May-05-22 Downgrade H.C. Wainwright Buy → Neutral
May-05-22 Downgrade SVB Leerink Outperform → Mkt Perform
May-04-22 Downgrade Northland Capital Outperform → Market Perform
May-12-21 Downgrade Goldman Neutral → Sell
Sep-29-20 Resumed JP Morgan Neutral
Aug-26-20 Initiated Piper Sandler Overweight
May-05-20 Initiated Northland Capital Outperform
Mar-31-20 Downgrade Goldman Buy → Neutral
Mar-31-20 Downgrade Jefferies Buy → Hold
Mar-31-20 Upgrade Oppenheimer Underperform → Perform
Mar-13-20 Upgrade Goldman Neutral → Buy
Mar-02-20 Initiated Cowen Outperform
Feb-18-20 Upgrade Citigroup Neutral → Buy
Jan-06-20 Initiated JP Morgan Neutral
Dec-16-19 Downgrade Stifel Buy → Hold
Nov-20-19 Initiated Oppenheimer Underperform
Nov-18-19 Downgrade Citigroup Buy → Neutral
Nov-15-19 Reiterated SVB Leerink Outperform
Oct-31-19 Initiated Aegis Capital Buy
Oct-15-19 Initiated Goldman Neutral
Aug-14-19 Initiated SVB Leerink Outperform
Jul-09-19 Reiterated Jefferies Buy
Jun-17-19 Initiated ROTH Capital Buy
Mar-22-19 Initiated Stifel Buy
View All

Amarin Corp Adr Stock (AMRN) Latest News

pulisher
Feb 06, 2025

Check Out Netgear Inc (NTGR)’s Trade Data Rather Than the Analysts’ Views - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Views of Wall Street’s Leading Experts on SciSparc Ltd - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Stocks of Talen Energy Corp (TLN) are poised to climb above their peers - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

Scholar Rock Holding Corp (SRRK) requires closer examination - US Post News

Feb 05, 2025
pulisher
Feb 05, 2025

Amarin Corp ADR (AMRN) shows promising results - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Analysts review Amarin Corp ADR’s rating - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

ALLY’s latest rating updates from top analysts. - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Ratios Uncovered: Breaking Down Amarin Corp ADR (AMRN)’s Trailing Twelve Months Metrics - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Ratio Review: Analyzing Caleres Inc (CAL)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Financial Health Report: Tevogen Bio Holdings Inc (TVGN)’s Ratios Tell a Tale - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Financial Metrics Exploration: Understanding Opendoor Technologies Inc (OPEN) Through Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Potential Price Increase for Godaddy Inc (GDDY) After Recent Insider Activity - Knox Daily

Feb 04, 2025
pulisher
Jan 24, 2025

Analyzing Ratios: Amarin Corp ADR (AMRN)’s Financial Story Unveiled - The Dwinnex

Jan 24, 2025
pulisher
Jan 21, 2025

Establishment Labs Holdings Inc (ESTA) expanding its growth trajectory ahead - SETE News

Jan 21, 2025
pulisher
Jan 03, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN

Jan 03, 2025
pulisher
Dec 19, 2024

Amarin stock touches 52-week low at $0.45 amid challenges - Investing.com

Dec 19, 2024
pulisher
Dec 16, 2024

Italy grants VAZKEPA reimbursement for heart risk - Investing.com

Dec 16, 2024
pulisher
Dec 14, 2024

Amarin Corporation plc (ADR) : Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG) - Marketscreener.com

Dec 14, 2024
pulisher
Dec 13, 2024

Amarin appoints new chief financial officer - Investing.com

Dec 13, 2024
pulisher
Dec 13, 2024

Amarin Appoints Peter Fishman Chief Financial Officer - GlobeNewswire Inc.

Dec 13, 2024
pulisher
Dec 11, 2024

Amarin stock plunges to 52-week low of $0.46 amid challenges - Investing.com

Dec 11, 2024
pulisher
Nov 24, 2024

Amarin granted extension to meet Nasdaq listing standards - Investing.com

Nov 24, 2024
pulisher
Nov 21, 2024

European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN

Nov 21, 2024
pulisher
Nov 20, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

European Equities Traded in the US as American Depositary Move Higher in Monday Trading - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN) - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga

Nov 19, 2024
pulisher
Nov 11, 2024

Amarin stock touches 52-week low at $0.55 amid market challenges - Investing.com

Nov 11, 2024
pulisher
Nov 10, 2024

European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday - MSN

Nov 10, 2024
pulisher
Nov 06, 2024

A Must-See Look at Amarin's Best- and Worst-Case Scenarios - AOL

Nov 06, 2024
pulisher
Oct 31, 2024

Amarin's Q3 Earnings In Line, Revenues Fall Shy Of Estimates - Barchart

Oct 31, 2024
pulisher
Oct 31, 2024

Earnings call: Amarin reports Q3 revenue dip amid U.S. generic competition - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript - AOL

Oct 31, 2024
pulisher
Oct 25, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Amarin stock plunges to 52-week low of $0.56 amid market challenges - Investing.com India

Oct 24, 2024
pulisher
Oct 18, 2024

European Equities Traded in the US as American Depositary Receipts Decline Tuesday - MSN

Oct 18, 2024
pulisher
Oct 15, 2024

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN

Oct 15, 2024
pulisher
Oct 14, 2024

Amarin Corp ADR [AMRN] Investment Guide: What You Need to Know - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

The growth track for Amarin Corp ADR (AMRN) has changed recently - SETE News

Oct 14, 2024
pulisher
Oct 14, 2024

BofA Securities downgrades Agilon Health Inc (AGL) stock to an Underperform - Knox Daily

Oct 14, 2024
pulisher
Oct 09, 2024

Amarin Corp ADR (AMRN) requires closer examination - US Post News

Oct 09, 2024
pulisher
Oct 08, 2024

Investing in Amarin Corp ADR (AMRN): What You Must Know - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Take off with Amarin Corp ADR (AMRN): Get ready for trading - SETE News

Oct 08, 2024
pulisher
Oct 08, 2024

Keeping an Eye on Bicycle Therapeutics Plc ADR (BCYC) After Insider Trading Activity - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Capital One Financial Corp.’s latest rating changes from various analysts - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Opthea expands leadership team amid clinical trials - Investing.com

Oct 08, 2024
pulisher
Oct 04, 2024

AMRN Stock Sees Surge of Approximately 1.68% in Last Five Days - Knox Daily

Oct 04, 2024
pulisher
Oct 03, 2024

Amarin Corp ADR (AMRN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Oct 03, 2024
pulisher
Oct 02, 2024

Amarin Corp ADR’s results are impressive - US Post News

Oct 02, 2024
pulisher
Oct 01, 2024

JP Morgan’s latest rating for AMRN stock - Knox Daily

Oct 01, 2024
pulisher
Oct 01, 2024

Stocks of Amarin Corp ADR (AMRN) are poised to climb above their peers - SETE News

Oct 01, 2024

Amarin Corp Adr Stock (AMRN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$98.04
price down icon 1.62%
drug_manufacturers_general SNY
$52.87
price down icon 1.18%
drug_manufacturers_general PFE
$25.83
price down icon 2.31%
$297.78
price down icon 3.26%
drug_manufacturers_general NVS
$106.98
price down icon 2.58%
drug_manufacturers_general MRK
$88.05
price down icon 1.81%
Cap:     |  Volume (24h):